Prophylaxis against Pneumocystis jirovecii pneumonia in patients with adult T-cell lymphoma/leukemia receiving anti-CC chemokine receptor 4 monoclonal antibody

J Infect. 2015 Dec;71(6):700-2. doi: 10.1016/j.jinf.2015.08.009. Epub 2015 Sep 5.

Authors

Satoshi Yamasaki¹, Kentaro Kohno², Masanori Kadowaki², Ken Takase², Seiichi Okamura²

Affiliations

¹ Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan. Electronic address: yamas009@kyumed.jp.
² Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

PMID: 26344926
DOI: 10.1016/j.jinf.2015.08.009

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Antifungal Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cohort Studies
Female
Humans
Leukemia-Lymphoma, Adult T-Cell / complications
Leukemia-Lymphoma, Adult T-Cell / drug therapy*
Male
Pneumocystis carinii*
Pneumonia, Pneumocystis / drug therapy
Pneumonia, Pneumocystis / prevention & control*
Receptors, CCR4 / immunology
Retrospective Studies
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Antibodies, Monoclonal, Humanized
Antifungal Agents
Receptors, CCR4
Trimethoprim, Sulfamethoxazole Drug Combination
mogamulizumab